vancomycin has been researched along with Diarrhea in 260 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (17.69) | 18.7374 |
| 1990's | 28 (10.77) | 18.2507 |
| 2000's | 50 (19.23) | 29.6817 |
| 2010's | 118 (45.38) | 24.3611 |
| 2020's | 18 (6.92) | 2.80 |
| Authors | Studies |
|---|---|
| Cloud, JW; Espinoza, D; Kelly, CP; Kokkotou, E; Michos, A; Moss, AC; Mustafa, N; O'Brien, M; Pothoulakis, C | 1 |
| Citron, D; He, Y; Herradura, P; Howland, K; Keith, D; Li, J; Mascio, CT; Mesleh, MF; Metcalf, C; Mortin, LI; Pearson, A; Silverman, J; Steenbergen, J; Thorne, GM; Van Praagh, AD; Yin, N | 1 |
| Dilmaghani, S; Fortes, BH; Ryan, SM | 1 |
| Chiu, CW; Hung, YP; Ko, WC; Lee, CC; Lee, JC; Tsai, PJ | 1 |
| Abiri, R; Alvandi, A; Fathollahi, M; Kadivarian, S; Motamedi, H; Rostamian, M | 1 |
| Calais, LA; Climo, MW; Donskey, CJ; Ge, L; Gerding, DN; Goetz, MB; Goldberg, AM; Gordin, FM; Gupta, K; Haegerich, T; Johnson, M; Johnson, N; Johnson, S; Li, X; Reda, DJ; Ringer, R | 1 |
| Leahy, RG; Serio, AW; Tanaka, SK; Traczewski, MM; Wright, K | 1 |
| Ball, IA; Bateman, E; Bowen, JM; Keefe, DM; Secombe, KR; Wignall, AD | 1 |
| Andreasen, SE; Baunwall, SMD; Dahlerup, JF; Damsgaard, EMS; Eriksen, LL; Erikstrup, C; Hansen, MM; Hvas, CL; Høyer, KL; Kelsen, J; Mikkelsen, S; Rågård, N; Rubak, T; Støy, S | 1 |
| Dinleyici, EÇ; Kara, Y; Kılıç, Ö; Kızıl, MC; Us, T | 1 |
| Moonah, S; Shirley, DA; Tornel, W; Warren, CA | 1 |
| Castagnola, E; Lo Porto, D; Mularoni, A; Saffioti, C | 1 |
| Garza, MA; Mathur, N; Nabbout, L; Quigley, EMM; Saleh, A; Thomas, B | 1 |
| Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M | 1 |
| Chow, A; Lye, DC; Ng, TM; Tay, HL | 1 |
| Adachi, S; Hasegawa, H; Kaku, N; Kosai, K; Matsumoto, N; Morinaga, Y; Osaki, M; Sasaki, D; Tagami, A; Tsuda, K; Uno, N; Yanagihara, K | 1 |
| Dai, W; Niu, S; Sun, J; Wang, Z; Xia, Y; Yan, L; Yang, T; Zhang, C | 1 |
| Sugimoto, H; Sugimoto, K; Yamamoto, T; Yoshihara, A | 1 |
| Polage, CR; Turner, NA | 1 |
| Khodaparast, S; Khoramabadi, N; Mohabati Mobarez, A; Saberifiroozi, M; Vasei, M | 1 |
| Kim, YJ; Kim, YK; Kwon, HI; Lee, HS; Lee, JC; Lee, WK; Na, SH; Nicholas, A; Selasi, GN; Shin, JH; Song, KE | 1 |
| De Puy, F; Kay, GN | 1 |
| Bhala, N; Iqbal, TH; Moore, D; Price, M; Quraishi, MN; Sharma, N; Widlak, M | 1 |
| Chen, HX; Luo, YP; Shen, YY; Song, LJ; Suo, L; Wang, R | 1 |
| Baharith, H; Ford, AC; Moayyedi, P; Yuan, Y | 1 |
| Álvarez-Lobos, M; Díaz-González, F; Paredes-Sabja, D; Pizarro-Guajardo, M | 1 |
| Backo, JL; Broderick, KC; Corvino, FA; Reveles, KR; Zivkovic, M | 1 |
| Kupiec, KE; Liu, C; Miller, JL; Schmidt, SA; Skrepnek, GH; Smith, WJ; Tieu, JD | 1 |
| Chen, YB; Fang, YH; Gu, SL; Li, LJ; Lv, T; Shen, P; Tang, LL | 1 |
| Squellati, R | 1 |
| Chang, HJ; Chen, CL; Chia, JH; Chiu, CH; Chuang, CH; Kuo, AJ; Lai, HC; Lu, CC; Su, LH; Wu, TL; Wu, TS | 1 |
| Anders, S; Garcia-Diaz, J; Hand, J; Li, J; Nguyen, CT; Staffeld-Coit, C | 1 |
| Dow, DE; Seed, PC | 1 |
| Drennan, K; Fabian, J; Gaylard, PC; Hepple, A; Karlsson, K; Lee, S; Lowman, W; McNamara, L; Simons, G | 1 |
| Mullish, BH; Williams, HR | 1 |
| Wilson, A | 1 |
| Gandhi, S; Patel, D; Sohal, S | 1 |
| Fernández Lisón, LC; Malpartida Flores, M; Martín Rizo, L | 1 |
| Fang, Z; Jiang, M; Liu, Y; Lv, X; Ren, W; Zhang, J | 1 |
| Berthiller, J; Chardot, C; Duclaux-Loras, R; Ferroni, A; Goulet, O; Lacaille, F; Norsa, L | 1 |
| Alvarez, AM; Rathore, MH | 1 |
| Abel-Santos, E; Howerton, A; Patra, M | 1 |
| Berg, AM; Farraye, FA | 1 |
| Beamer, G; Bowlin, T; Butler, M; Steele, J; Tzipori, S; Zhang, Q | 1 |
| Cornely, OA; Fantin, B; Gorbach, S; Kean, Y; Miller, MA; Mullane, K | 1 |
| Dijkgraaf, MG; Keller, JJ; van Nood, E | 1 |
| Gross, A; Kalil, AC; Van Schooneveld, TC | 1 |
| Hataye, JM; Palmore, TN; Powers, JH | 1 |
| Ramsauer, B | 1 |
| Lehrer, S | 1 |
| Baji, P; Banai, J; Brodszky, V; Gulácsi, L; Kertész, A; Kopcsóné Németh, I; Ludwig, E; Péntek, M; Prinz, G; Reményi, P; Strbák, B; Zsoldiné Urbán, E | 2 |
| Clutter, DS; Dubrovskaya, Y; Merl, MY; Press, R; Safdar, A; Teperman, L | 1 |
| Jindai, K; Kunzer, B; O'Horo, JC; Safdar, N | 1 |
| Tart, SB | 1 |
| de Vrieze, J | 1 |
| Gardner, TB; Levy, LC; Sampath, K | 1 |
| Keller, JJ | 1 |
| Abujamel, T; Cadnum, JL; Donskey, CJ; Jump, RL; Jury, LA; Kundrapu, S; Stintzi, AC; Sunkesula, VC | 1 |
| Bass, SN; Bauer, SR; Lam, SW; Neuner, EA | 1 |
| Cornely, OA; Fantin, BR; Gorbach, SL; Kean, Y; Miller, MA; Mullane, KM | 1 |
| Acharya, UH; Green, MR; Yeager, AM | 1 |
| Cojocariu, C; Dorobat, C; Girleanu, I; Grigore, L; Sfarti, C; Singeap, AM; Stanciu, C; Trifan, A | 1 |
| Keller, JM; Surawicz, CM | 1 |
| Gross, M; Meyer, C | 1 |
| Enser, JJ; Hess, TM; Hsu, JL; Leverson, GE; McKown, T; Pirsch, JD; Safdar, N | 1 |
| Curry, SR; Marsh, JW | 1 |
| Wilcox, MH | 2 |
| Broom, C; Chasan-Taber, S; Cornely, OA; Davidson, DM; Fitts, D; Gelone, SP; Gerding, DN; Johnson, S; Louie, TJ | 1 |
| Miigoć, H; Piekarska, M; Wandałowicz, AD | 1 |
| Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M | 1 |
| Christenson, ES; Hsu, S; Ligon, C | 1 |
| Biswas, JS; Goldenberg, SD; Newsholme, W; Otter, JA; Patel, A; van Kleef, E; Wade, P | 1 |
| Bibbò, S; Cammarota, G; Costamagna, G; Dinoi, G; Gasbarrini, A; Ianiro, G; Masucci, L; Sanguinetti, M | 1 |
| Alm, E; Burgess, J; Burns, L; Didyk, E; Edelstein, C; Giovanelli, A; Kassam, Z; Mendolia, G; Noh, A; Smith, M; Stollman, N | 1 |
| Carreiro, FT; Coelho, SC; Horta, AB; Sá, J | 1 |
| Demura, K; Imagawa, A; Kameyama, M; Kawasaki, M; Mizumura, N; Ogawa, M; Ohba, K; Okumura, S; Toyoda, S | 1 |
| English, TM; McCreary, EK; Wargo, KA | 1 |
| Vaishnavi, C | 1 |
| Cai, P; Chen, L; Cheng, G; Dai, X; Li, Z; Wang, Z; Zhang, Z | 1 |
| Acuña, G; Moscoso, F; Quera, R; Rivera, D; Simian, D | 1 |
| Doron, S; Gorbach, S; Mizusawa, M | 1 |
| Forbes, BA; Gerding, DN; Goldstein, EJ; Jacobus, NV; Jenkins, SG; Johnson, S; McDermott, LA; Mirrett, S; Patel, R; Snydman, DR; Stone, S; Thorpe, C | 1 |
| Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Kracker, H; Louie, T; Nord, CE; Talbot, GH; Wilcox, M | 1 |
| Arrabal-Durán, P; Hidalgo-Collazos, P; López González-Cobos, C; Sanjurjo-Sáez, M | 1 |
| Danielsen, TK; Holt, HM; Justesen, US | 1 |
| Greenberg, A; Matta, SK; Singh, A | 1 |
| Anguita, P; Cobo Reinoso, J; Gani, R; Grau Cerrato, S; Mensa Pueyo, J; Rubio-Rodríguez, D; Rubio-Terrés, C; Salavert Lletí, M; Toledo, A; Watt, M | 1 |
| Cojocariu, C; Girleanu, I; Miftode, E; Singeap, AM; Stanciu, C; Stoica, O; Trifan, A | 1 |
| Clozel, M; Enderlin-Paput, M; Locher, HH; Pfaff, P; Ritz, D; Seiler, P; Weiss, M | 1 |
| Bahl, MI; Frost, M; Hansen, T; Holst, JJ; Jensen, US; Knop, FK; Licht, TR; Mikkelsen, KH; Pedersen, O; Rehfeld, JF; Rosenberg, J; Vilsbøll, T | 1 |
| Bernard, S; Block, BL; Schwartzstein, RM | 1 |
| Akkoc, G; Atici, S; Bakir, M; Karaaslan, A; Kepenekli Kadayifci, E; Ocal Demir, S; Sarmis, A; Soysal, A; Ulger Toprak, N; Yakut, N | 1 |
| Baloun, B; Gilbert, J; Nelson, C; Wiedel, N | 1 |
| del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T | 1 |
| Telekes, A | 1 |
| Cooper, P; Groß, U; Gunka, K; Janssen, I; Rupnik, M; Wetzel, D; Zimmermann, O | 1 |
| Boccuzzi, E; Borali, E; Castellazzi, L; Cursi, L; De Giacomo, C; De Vita, MV; Esposito, S; Garazzino, S; Guarino, A; Lancella, L; Lo Vecchio, A; Mainetti, M; Tagliabue, C | 1 |
| Stallmach, A | 1 |
| Coburn, B; Guttman, DS; Hota, SS; Low, DE; McGeer, A; Poutanen, SM; Sales, V; Salpeter, MJ; Tomlinson, G | 1 |
| Hermsen, ED; Meza, JL; Njoku, JC; Olsen, KM; Qiu, F; Rupp, ME; Van Schooneveld, TC | 1 |
| Anastasiou, D; Arnold, SR; Arrieta, A; Bokesch, P; Bradley, J; Congeni, B; Daum, RS; Glasser, C; Kojaoghlanian, T; Patino, H; Wolf, DJ; Yoon, M | 1 |
| Banaei, N; Deresinski, S; Gombar, S; Holubar, M; Madison, A; Schroeder, LF; Shah, N; Shepard, J; Sundararajan, G; Tekic, N; Tompkins, L; Truong, CY; Wilson, R | 1 |
| Evans, CT; Nelson, RL; Suda, KJ | 1 |
| Fujimoto, Y; Ishida, Y; Konishi, H; Kowata, S; Morimoto, Y; Nomura, K; Ohshiro, M; Oyake, T; Sato, K; Taniwaki, M; Yamashita, M; Yoshikawa, T | 1 |
| Bartelsman, JF; Jansen, JM; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; van Heukelem, HA; van Nood, E; Visser, CE | 1 |
| Evans, D; Scott, D; Shakur, R | 1 |
| Cheknis, A; Chen, X; Gerding, DN; Goldsmith, JD; Katchar, K; Kelly, CP; Nanthakumar, N | 1 |
| Bujanda, L; Cosme, A | 1 |
| Kelly, CP | 3 |
| Byker, GL; Dinh, MT; Gunaratnam, NT; Malani, AN; Robinson, EA; Shehab, TM | 1 |
| Johnson, S | 1 |
| Shen, B; Wang, Y | 1 |
| Dubberke, ER; Riddle, DJ | 1 |
| Ambrosino, DM; Baxter, R; Blair, BM; Gerding, DN; Hay, CA; Leav, BA; Leney, M; Lowy, I; Molrine, DC; Nichol, G; Sloan, S; Thomas, WD | 1 |
| Gkrania-Klotsas, E; Nicholl, C; Parks, T; Wallis, S; Wilson, J | 1 |
| Simor, AE | 1 |
| Jeong, JB; Jung, HC; Kim, BG; Kim, JS; Kim, JW; Lee, KL; Shin, S; Song, IS | 1 |
| Salkind, AR | 1 |
| Byrne, B; Emery, J; Lawley, B; Louie, T; Munro, K; Tannock, GW; Taylor, C; Young, W | 1 |
| Abraham, P; Desai, D; Deshmukh, A; Ingle, M; Joshi, A; Mankeshwar, R; Rodrigues, C | 1 |
| Amoros, F; Borrás-Blasco, J; Enriquez, R; Navarro-Ruiz, A; Padilla, S; Sirvent, AE; Solavera, J | 1 |
| Garg, B; Kumar, V; Madan, M; Malhotra, R | 1 |
| Kang, JO; Kim, J; Pai, H; Seo, MR | 1 |
| Jahamy, H; Johnson, LB; Khatib, R; Patel, SM; Riederer, K; Shemes, SP; Szpunar, S; Valenti, S; Venugopal, AA | 1 |
| Malkan, AD; Scholand, SJ | 1 |
| Bliss, D; Butler, M; Drekonja, DM; Filice, GA; MacDonald, R; Rector, TS; Wilt, TJ | 1 |
| Kee, VR | 1 |
| Cornely, OA; Crook, DW; Esposito, R; Gorbach, S; Poirier, A; Sears, P; Somero, MS; Weiss, K | 1 |
| Armbruster, S; Goldkind, L | 1 |
| Gerding, DN; Gorbach, SL; Johnson, S; Louie, TJ; Ruiz, NM | 1 |
| Anderson, DJ; Chen, LF | 1 |
| Citron, DM; Figueroa, I; Gerding, DN; Goldstein, EJ; Johnson, S; Sambol, SP | 1 |
| Allgren, RL; Sellers, S; Weiss, K | 1 |
| Angus, BJ; Cornely, OA; Crook, DW; Esposito, R; Gorbach, SL; Kean, Y; Louie, TJ; Miller, MA; Peto, TE; Stoesser, NE; Walker, AS; Weiss, K; Young, BC | 1 |
| Caballero, J; Rivas, KM; Sizemore, EN; Valdes, J | 1 |
| Bossé, D; Cantin, AM; Lemire, C; Ménard, F; Ruel, J; Valiquette, L | 1 |
| Ha, D; Tsai, CJ | 1 |
| Khanna, S; Pardi, DS | 1 |
| Bracken, TC; Figler, RA; Guerrant, RL; Kolling, G; Li, Y; Linden, J; Rieger, J; Stevenson, RW; Warren, CA | 1 |
| Bartelsman, JF; de Vos, WM; Dijkgraaf, MG; Fuentes, S; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; Tijssen, JG; van Nood, E; Visser, CE; Vrieze, A; Zoetendal, EG | 1 |
| Malnick, SD; Zimhony, O | 1 |
| Alcázar Montero, MS; Gimeno Aranguez, M; Navarro Gaspar, C; Vilalta Castel, E | 1 |
| Lenzen-Grossimlinghaus, R; Strohmeyer, G | 1 |
| Martirosian, G; Szczesny, A | 1 |
| Alary, ME; Chouinard, D; Forget, K; Pelletier, A; Pépin, J; Pépin, K; Valiquette, L; Villemure, P | 1 |
| Anton, PM; Eisenstein, B; Kelly, CP; Kokkotou, E; Michaelis, A; O'Brien, M; Paraschos, S; Pothoulakis, C; Rothstein, D | 1 |
| Oldfield, EC | 1 |
| Chek, K; Meadows, S; Ohl, ME; Stevermer, JJ; Tribuna, J | 1 |
| Parmar, MS | 1 |
| Schroeder, MS | 1 |
| Surawicz, CM | 1 |
| Brazier, J; Burmeister, S; Lewis, S | 1 |
| Alonso, R; Bouza, E; Muñoz, P | 1 |
| Starr, J | 1 |
| Arango, JI; Bradshaw, P; Callander, NS; Freytes, CO; Ochoa-Bayona, JL; Patterson, J; Restrepo, A; Restrepo, MI; Schneider, DL | 1 |
| Daum, RS; Glikman, D; Kahanna, M; Vora, S | 1 |
| Ellis, R; McPherson, S; Panter, SJ; Rees, CJ; Soo, S | 1 |
| Jakobsen, L; Tvede, M | 1 |
| Cadle, RM; Darouiche, RO; Mansouri, MD | 1 |
| Høiby, N; Tvede, M | 1 |
| Chasan-Taber, S; Davidson, DM; Dow, G; Garber, G; John, JF; Johnson, D; Louie, TJ; Mohammed, R; Peppe, J; Simon, S; Watt, CK; Weiss, K | 1 |
| Bouza, E; Burillo, A; Muñoz, P | 1 |
| Galang, M; Gerding, DN; Johnson, S; Kelly, CP; Schriever, C | 1 |
| Hornillos Calvo, M; Pareja Sierra, T | 1 |
| Hassoun, A; Ibrahim, F | 1 |
| Nelson, R | 1 |
| Pakyz, A | 1 |
| Bishara, J; Paul, M; Wattad, M | 1 |
| Huggan, PJ; Murdoch, DR | 1 |
| Dubberke, ER; Gerding, DN; Johnson, S; Lawrence, SJ | 1 |
| Al-Nassir, WN; Bobulsky, GS; Donskey, CJ; Jump, RL; Nerandzic, MM; Sethi, AK | 1 |
| Funada, H; Hattori, K; Ishizaki, T; Kuroda, T; Nakamura, S | 1 |
| Gebhard, RL; Gerding, DN; Lee, JT; Olson, MM; Peterson, LR; Schwartz, MJ; Teasley, DG | 1 |
| Remington, H; Standing, VF | 1 |
| Gordon, RS | 1 |
| Bartlett, JG | 1 |
| Burdon, DW | 1 |
| Buggy, B; Deery, HG; Fekety, R; Silva, J | 1 |
| Baer, M; Grönroos, P; Mäki, M; Vesikari, T | 1 |
| Koornhof, HJ; Miller, SD | 1 |
| Dudley, MN; Gontarz, N; Nightingale, CH; Quintiliani, R | 1 |
| Dowell, VR; Michelich, VJ; Nunez-Montiel, O; Schuster, GS; Thompson, F | 1 |
| Bartlett, JG; Chang, TW; Flores, A; Grand, RJ; Sutphen, JL | 1 |
| Blake, M; Koornhof, HJ; Miliotis, M; Miller, SD; Still, C; Taubin, A | 1 |
| Loeschke, K | 1 |
| Cudmore, MA; Fekety, R; Kim, KH; Liepman, MK; Silva, J | 1 |
| Harvey, K; McDonald, M; Ward, P | 1 |
| Faulkner, RS; Furlong, M; Haldane, EV; Kerr, EA; Marrie, TJ; Sidorov, J | 1 |
| Lamont, JT; Levine, HG | 1 |
| George, WL | 2 |
| Murray, D; Portnoy, D; Richards, GK; Soneji, A | 1 |
| Baillargeon, J; Bayardelle, P; Beaudoin, M; Caussignac, Y; Emond, M; Jarry, M | 1 |
| Baird, I; Batts, DH; Fekety, R; Plouffe, JF; Rifkin, GD; Silva, J | 1 |
| Batts, DH; Fekety, FR; Holmes, R; Martin, D; Silva, J | 1 |
| Finegold, SM; George, WL; Rolfe, RD | 1 |
| Pote, HH; Schenfeld, LA | 1 |
| Bell, B; Cooper, M; Golledge, CL; Riley, TV | 1 |
| Cartmill, TD; Keith, E; McCann, DC; Nice, CN; Panigrahi, H; Worsley, MA | 1 |
| Bacon, AE; Caputo, GM; Weitekamp, MR; Whitener, C | 1 |
| Boyce, JM; Chow, JW; Fortna, S; Medeiros, AA; Opal, SM; Potter-Bynoe, G; Romulo, RL; Sherman, CB; Zervos, MJ | 1 |
| Brandt, LJ; Lu, SS; Schwartz, JM; Simon, DM | 1 |
| Jacobs, NF | 1 |
| Cappell, MS; Philogene, C | 1 |
| Borucki, MJ; Clench, MH; Cozart, JC; Kalangi, SS; Pollard, RB; Soloway, RD; Taylor, DR | 1 |
| Howe, R; Wilcox, MH | 1 |
| Johnson, TR; Pitt, HA; Sciscione, AC; Villeneuve, JB | 1 |
| Graninger, W; Hasenhündl, M; Hirschl, AM; Parschalk, B; Wenisch, C | 1 |
| Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Mulligan, ME; Surawicz, CM | 1 |
| Hunter, MP; Richards, GA | 1 |
| Kelly, CP; LaMont, JT | 1 |
| Hager, K; Ruwe, A | 1 |
| Bailey, EM | 1 |
| Calişkaner, Z; Koçar, IH; Pay, S; Turan, M | 1 |
| Luk, WK; Wong, SS; Woo, PC; Yuen, KY | 1 |
| Adal, K; Andresen, S; Avery, R; Bolwell, B; Goldman, M; Hall, G; Kalaycio, M; Longworth, D; Mason, P; Mossad, S; Pohlman, B; Schmitt, S | 1 |
| Cook, GM; Keis, S; Kobayashi, K; Rainey, FA; Rao, M; Smith, JM | 1 |
| Gerding, DN | 1 |
| Calderwood, SB; Mylonakis, E; Ryan, ET | 1 |
| Bettelheim, KA; Djordjevic, SP; Hornitzky, MA | 1 |
| Prescott, LM | 1 |
| Linday, LA | 1 |
| Kerst, JM; Kuijper, EJ; van der Lelie, J | 1 |
| Bouza, E; Muñòz, P; Palomo, J; Yáñèz, J | 1 |
| Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
| Siristonpun, Y; Tanphaichitra, D | 1 |
| Esposito, AL; Gleckman, RA | 1 |
| Del Favero, A; Menichetti, F; Morelli, A; Narducci, F; Pelli, MA | 1 |
| Arabi, Y; Bentley, S; Burdon, DW; George, RH; Johnson, M; Keighley, MR; Mogg, GA; Thompson, H; Williams, JA; Youngs, D | 1 |
| Blomberg, S; Möllby, R; Nord, CE; Röjdmark, S | 1 |
| Crow, J; Larson, HE; Price, AB | 1 |
| Alexander-Williams, J; Arabi, Y; Brown, JD; Burdon, DW; George, RH; Keighley, MR; Shinagawa, N; Youngs, DJ | 1 |
| Broitman, SA; Katz, L; LaMont, JT; Rieth, S; Rothman, SW; Sonnenblick, EB; Trier, JS | 1 |
| de Lalla, F; Manfrin, V; Nicolin, R; Rigoli, R; Rinaldi, E; Scarpellini, P; Tramarin, A | 1 |
| Fruhmann, K; Krotenberg, R; Yablon, SA | 1 |
| Dworczyński, A; Meisel-Mikołajczyk, F; Sokół, B | 1 |
| Barbadora, K; Green, M; Wadowsky, RM | 1 |
| Ebina, K; Hirano, T; Ohi, H; Sugawara, A | 1 |
| Wheeler, WE; Yarinsky, S | 1 |
| Cerf, M; Levecq, H | 1 |
| de Lalla, F; Ortisi, G; Privitera, G; Rinaldi, E; Rizzardini, G; Santoro, D | 1 |
| Baird, DR | 1 |
| Barbezat, GO; Cooper, BT; Lee, DK | 1 |
| Buggy, B; Deery, HG; Fekety, R; Kauffman, C; Silva, J | 1 |
| Cardines, R; Gianfrilli, P; Luzzi, I; Pantosti, A | 1 |
| Corrado, ML; Hesney, M; Struble, WE | 1 |
| Carrington, G; Dudley, MN; Frick, J; McLaughlin, JC; Nightingale, CH; Quintiliani, R | 1 |
| Barclay, F; Bonnycastle, M; Borriello, SP; Piper, M; Seal, D; Welch, A | 1 |
| Buggy, BP; Fekety, R; Silva, J | 1 |
| Bistrian, BR; Blackburn, GL; Tayek, JA | 1 |
| Church, JM; Fazio, VW | 1 |
| Adams, GL; Griebie, M | 1 |
55 review(s) available for vancomycin and Diarrhea
| Article | Year |
|---|---|
A worldwide systematic review and meta-analysis of bacteria related to antibiotic-associated diarrhea in hospitalized patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chloramphenicol; Ciprofloxacin; Clostridioides difficile; Clostridium perfringens; Diarrhea; Humans; Klebsiella oxytoca; Metronidazole; Prevalence; Staphylococcus aureus; Vancomycin | 2021 |
Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy.
Topics: Adult; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Humans; Vancomycin | 2023 |
Clostridioides difficile infection in the allogeneic hematopoietic cell transplant recipient.
Topics: Adult; Anti-Bacterial Agents; Child; Clostridium Infections; Diarrhea; Fidaxomicin; Hematopoietic Stem Cell Transplantation; Humans; Transplant Recipients; Vancomycin | 2023 |
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
Topics: Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fecal Microbiota Transplantation; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2017 |
Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Feces; Humans; Randomized Controlled Trials as Topic; Vancomycin | 2017 |
Evidence-Based Practice in the Treatment for Antibiotic-Associated Diarrhea in the Intensive Care Unit.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Critical Care Nursing; Cross Infection; Diarrhea; Evidence-Based Practice; Humans; Intensive Care Units; Proton Pump Inhibitors; Risk Factors; Vancomycin | 2018 |
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Metronidazole; Probiotics; Vancomycin | 2018 |
Antibiotic Treatment for Clostridium difficile Infection in Adults.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Vancomycin | 2018 |
Clostridium difficile Infection in Children.
Topics: Age Factors; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Humans; Incidence; Male; Metronidazole; Prognosis; Risk Assessment; Sex Factors; United States; Vancomycin | 2019 |
[Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2013 |
Treatment of recurrent Clostridium difficile infection: a systematic review.
Topics: Anti-Infective Agents; Biological Therapy; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Humans; Metronidazole; Secondary Prevention; Treatment Outcome; Vancomycin | 2014 |
[Clostridium difficile infection: epidemiology, disease burden and therapy].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cost of Illness; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Health Care Costs; Humans; Hungary; Metronidazole; Public Health; Recurrence; Seasons; Vancomycin | 2013 |
Clostridium difficile infection in the elderly.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Management; Humans; Metronidazole; Outcome Assessment, Health Care; Prevalence; Risk Factors; Severity of Illness Index; Vancomycin | 2014 |
[Clostridium difficile infecion--diagnostics, prevention and treatment].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Feces; Fidaxomicin; Humans; Metronidazole; Probiotics; Secondary Prevention; Vancomycin | 2014 |
Fidaxomicin--the new drug for Clostridium difficile infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Recurrence; Vancomycin | 2015 |
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2015 |
Clostridium difficile infection in patients with liver disease: a review.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diagnostic Tests, Routine; Diarrhea; Drug Therapy, Combination; Humans; Liver Cirrhosis; Liver Transplantation; Metronidazole; Treatment Outcome; Vancomycin | 2015 |
Lactococcus lactis spp lactis infection in infants with chronic diarrhea: two cases report and literature review in children.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Chronic Disease; Diarrhea; Female; Gram-Positive Bacterial Infections; Humans; Infant; Lactococcus lactis; Male; Vancomycin | 2016 |
[Oncologic aspects of Clostridium difficile].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Gastrointestinal Microbiome; Humans; Recurrence; Risk Factors; Vancomycin | 2016 |
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacitracin; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Randomized Controlled Trials as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2017 |
[Clostridium-difficile-associated diarrhea].
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Biological Therapy; Clostridioides difficile; Colectomy; Colonoscopy; Combined Modality Therapy; Cross Infection; Diarrhea; DNA, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant, Newborn; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Superinfection; Vancomycin | 2009 |
A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestines; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Severity of Illness Index; Vancomycin | 2009 |
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Treatment Outcome; Vancomycin | 2009 |
Clostridium difficile infection in the intensive care unit.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Incidence; Intensive Care Units; Metronidazole; Vancomycin | 2009 |
Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.
Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Equipment Contamination; Humans; Infection Control; Long-Term Care; Metronidazole; Risk Factors; Severity of Illness Index; Vancomycin | 2010 |
Clostridium difficile: an update for the primary care clinician.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Patient Isolation; Primary Health Care; Probiotics; Recurrence; Severity of Illness Index; Vancomycin | 2010 |
Comparative effectiveness of Clostridium difficile treatments: a systematic review.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Comparative Effectiveness Research; Diarrhea; Drug Therapy, Combination; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin | 2011 |
Clostridium difficile infection in older adults: a review and update on its management.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Infection Control; Metronidazole; Risk Factors; Vancomycin | 2012 |
Current strategies for management of initial Clostridium difficile infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Length of Stay; Metronidazole; Recurrence; Rehabilitation Centers; Risk Factors; Severity of Illness Index; Vancomycin | 2012 |
Safety analysis of fidaxomicin in comparison with oral vancomycin for Clostridium difficile infections.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Diarrhea; Dogs; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Fidaxomicin; Humans; Treatment Outcome; Vancomycin | 2012 |
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Eosinophils; Feces; Fidaxomicin; Humans; Intention to Treat Analysis; Leukocyte Count; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Vancomycin | 2012 |
Clostridium difficile infection: new insights into management.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Clostridium Infections; Diarrhea; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Vancomycin | 2012 |
Treatment of Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Drug Administration Schedule; Female; Humans; Infection Control; Metronidazole; Pregnancy; Severity of Illness Index; Vancomycin | 2002 |
[Treatment of infections associated with Clostridium difficile].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Species Specificity; Vancomycin | 2003 |
Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Humans; Metronidazole; Vancomycin | 2005 |
Clostridium difficile--associated diarrhea.
Topics: Aged; Algorithms; Anti-Infective Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Metronidazole; Vancomycin | 2005 |
Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Clinical Trials as Topic; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestinal Absorption; Lactobacillus; Metronidazole; Probiotics; Vancomycin | 2005 |
Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Vancomycin | 2005 |
Clostridium difficile associated diarrhoea: diagnosis and treatment.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Feces; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin | 2005 |
Antimicrobial therapy of Clostridium difficile-associated diarrhea.
Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Infant; Megacolon, Toxic; Metronidazole; Nitro Compounds; Risk Factors; Secondary Prevention; Thiazoles; Vancomycin | 2006 |
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Metronidazole; Teicoplanin; Treatment Outcome; Vancomycin | 2007 |
Antibiotic-associated colitis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Colitis; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Fluid Therapy; Humans; Metronidazole; Recurrence; Staphylococcal Infections; Vancomycin | 1984 |
Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Recurrence; Vancomycin | 1984 |
[Antibiotic-associated diarrhoea and enterocolitis (author's transl)].
Topics: Adult; Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1980 |
Diarrhea associated with parenteral vancomycin therapy.
Topics: Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Kidney Failure, Chronic; Male; Middle Aged; Staphylococcal Infections; Vancomycin | 1995 |
Clostridium difficile infection: a common clinical problem for the general internist.
Topics: Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Family Practice; Humans; Metronidazole; Vancomycin | 1994 |
Antibiotic-induced diarrhea and pseudomembranous colitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Cytotoxins; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Incidence; Infection Control; Metronidazole; Primary Prevention; Sensitivity and Specificity; Sigmoidoscopy; Vancomycin | 1994 |
Surgery for pancreatic tumors during pregnancy: a case report and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Cerebral Hemorrhage; Cesarean Section; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fetal Distress; Fluid Therapy; Humans; Infant, Newborn; Pancreatic Neoplasms; Postoperative Complications; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Risk Factors; Vancomycin | 1996 |
Clostridium difficile infection.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Drug Costs; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Exotoxins; Feces; Hospitalization; Humans; Intestinal Mucosa; Metronidazole; Recurrence; Time Factors; Vancomycin | 1998 |
Clostridium difficile infection in patients with reactive arthritis of undetermined etiology.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Reactive; Bacterial Toxins; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Feces; Female; Humans; Male; Prognosis; Prohibitins; Treatment Outcome; Vancomycin | 1998 |
Treatment of Clostridium difficile-associated diarrhea and colitis.
Topics: Abdomen, Acute; Anti-Bacterial Agents; Antidiarrheals; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Colectomy; Colitis; Combined Modality Therapy; Contraindications; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Intestinal Perforation; Megacolon, Toxic; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin | 2000 |
Clostridium difficile--Associated diarrhea: A review.
Topics: Clostridioides difficile; Colon; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Practice Guidelines as Topic; Radiography; Vancomycin | 2001 |
[Diarrhea due to Clostridium difficile toxin in hemato-oncological patients].
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clostridioides difficile; Dexamethasone; Diarrhea; Doxorubicin; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Middle Aged; Multiple Myeloma; Treatment Outcome; Vancomycin; Vincristine | 2001 |
New indications for old antibiotics: tetracycline, erythromycin, carbenicillin, and vancomycin revisited.
Topics: Anti-Bacterial Agents; Carbenicillin; Clindamycin; Diarrhea; Enterocolitis, Pseudomembranous; Erythromycin; Humans; Legionnaires' Disease; Lung Diseases; Male; Methicillin; Penicillin Resistance; Prostatitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Tetracycline; Urethritis; Vancomycin | 1979 |
[Antibiotics and pseudomembranous colitis].
Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Parenteral Nutrition, Total; Vancomycin; Water-Electrolyte Balance | 1979 |
31 trial(s) available for vancomycin and Diarrhea
| Article | Year |
|---|---|
Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; COVID-19; Diarrhea; Fidaxomicin; Humans; Recurrence; Treatment Outcome; Vancomycin | 2022 |
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial.
Topics: Clostridium Infections; Diarrhea; Double-Blind Method; Fecal Microbiota Transplantation; Humans; Vancomycin | 2022 |
Effect of probiotics on gut microbiome in patients with administration of surgical antibiotic prophylaxis: A randomized controlled study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Diarrhea; Drug Therapy, Combination; Enterococcus faecium; Feces; Female; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Probiotics; Prospective Studies; Spine; Vancomycin | 2020 |
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Secondary Prevention; Treatment Outcome; Vancomycin | 2013 |
Outcomes of Clostridium difficile infection in recipients of solid abdominal organ transplants.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Hospitalization; Humans; Kidney Transplantation; Length of Stay; Liver Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Vancomycin; Wisconsin | 2014 |
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Polymers; Recurrence; Sulfonic Acids; Vancomycin; Young Adult | 2014 |
Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Environmental Microbiology; Female; Fidaxomicin; Hospitalization; Humans; Male; Metronidazole; Vancomycin | 2015 |
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.
Topics: Adult; Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Microbiota; Middle Aged; Treatment Outcome; Vancomycin | 2015 |
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazolidinones; Patient Safety; Recurrence; Vancomycin | 2015 |
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Load; Blood Glucose; Diarrhea; Fasting; Feces; Gastrointestinal Hormones; Gastrointestinal Microbiome; Gentamicins; Glucose; Humans; Insulin; Male; Meropenem; Postprandial Period; Thienamycins; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Humans; Male; Microbiota; Middle Aged; Ontario; Recurrence; Vancomycin; Young Adult | 2017 |
Daptomycin for Complicated Skin Infections: A Randomized Trial.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Creatine Kinase; Daptomycin; Diarrhea; Drug Administration Schedule; Female; Fever; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Single-Blind Method; Skin Diseases, Bacterial; Vancomycin | 2017 |
Treatment with monoclonal antibodies against Clostridium difficile toxins.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal; Antitoxins; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Male; Metronidazole; Middle Aged; Secondary Prevention; Vancomycin; Young Adult | 2010 |
A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; DNA, Bacterial; Feces; Fidaxomicin; Humans; Intestines; Metagenome; Phylogeny; Vancomycin | 2010 |
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Vancomycin | 2012 |
Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Female; Fidaxomicin; Humans; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Vancomycin | 2012 |
Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Canada; Clostridioides difficile; Clostridium Infections; Diarrhea; DNA, Bacterial; Enterotoxins; Europe; Feces; Fidaxomicin; Humans; Middle Aged; Prohibitins; Secondary Prevention; Time Factors; United States; Vancomycin | 2012 |
Duodenal infusion of donor feces for recurrent Clostridium difficile.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Diarrhea; Duodenum; Feces; Female; Humans; Intubation, Gastrointestinal; Male; Metagenome; Middle Aged; Recurrence; Therapeutic Irrigation; Vancomycin | 2013 |
Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antidiarrheals; Bifidobacterium; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Oligosaccharides; Probiotics; Secondary Prevention; Treatment Outcome; Vancomycin | 2005 |
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Diarrhea; Double-Blind Method; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Ions; Male; Middle Aged; Polymers; Polystyrenes; Sulfonic Acids; Vancomycin | 2006 |
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.
Topics: Adult; Aged; Clinical Trials as Topic; Clostridium Infections; Colitis; Costs and Cost Analysis; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Random Allocation; Vancomycin | 1983 |
Clostridium difficile-associated diarrhea in patients with HIV positivity and AIDS: a prospective controlled study.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; HIV Seropositivity; Humans; Male; Metronidazole; Prospective Studies; Vancomycin | 1994 |
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Teicoplanin; Vancomycin | 1996 |
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Risk Factors; Seasons; Vancomycin | 1997 |
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Prevalence; Transplantation, Autologous; Vancomycin | 2000 |
Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.
Topics: Bacterial Toxins; Clinical Trials as Topic; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Postoperative Complications; Random Allocation; Vancomycin | 1978 |
Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Prospective Studies; Teicoplanin; Vancomycin | 1992 |
Treatment of Clostridium difficile-associated disease with teicoplanin.
Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cytotoxins; Diarrhea; Female; Glycopeptides; Humans; Male; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 1989 |
Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clostridium; Clostridium Infections; Colitis; Diarrhea; Humans; Infant; Middle Aged; Vancomycin | 1989 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestinal Diseases; Humans; Leukemia; Neutropenia; Norfloxacin; Skin Diseases; Sulfamethoxazole; Trimethoprim; Vancomycin | 1988 |
Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial.
Topics: Aged; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Middle Aged; Random Allocation; Recurrence; Time Factors; Vancomycin | 1986 |
174 other study(ies) available for vancomycin and Diarrhea
| Article | Year |
|---|---|
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
Topics: Animals; Anti-Infective Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Mesocricetus; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Weight Gain | 2008 |
Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Structure-Activity Relationship | 2015 |
34-Year-Old Woman With Human Immunodeficiency Virus and Chronic Diarrhea.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Chronic Disease; Diarrhea; Female; HIV Infections; Humans; Isospora; Isosporiasis; Vancomycin | 2021 |
Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Topics: Aged; Aged, 80 and over; Bacteriological Techniques; Clostridioides; Clostridioides difficile; Clostridium Infections; Diagnostic Tests, Routine; Diarrhea; Feces; Female; Humans; Immunoenzyme Techniques; Male; Metronidazole; Middle Aged; Multivariate Analysis; Treatment Outcome; Vancomycin | 2021 |
Activity of omadacycline in vitro against Clostridioides difficile and preliminary efficacy assessment in a hamster model of C. difficile-associated diarrhoea.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides; Clostridioides difficile; Cricetinae; Diarrhea; Metronidazole; Tetracyclines; Tigecycline; Vancomycin | 2022 |
Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats.
Topics: Animals; Anti-Bacterial Agents; Breast Neoplasms; Diarrhea; Female; Gram-Negative Bacteria; Humans; Neomycin; Quinolines; Rats; Receptor, ErbB-2; Vancomycin | 2022 |
Investigation of the use of multiplex PCR in childhood diarrhea with clinical and epidemiological features.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Diarrhea; Escherichia coli; Feces; Female; Gastroenteritis; Gastrointestinal Agents; Humans; Infant; Male; Multiplex Polymerase Chain Reaction; Retrospective Studies; Vancomycin | 2022 |
Look What the Cat Dragged in! Recurrent Clostridioides difficile from a Household Cat.
Topics: Adult; Animals; Anti-Bacterial Agents; Cats; Clostridioides; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Neoplasm Recurrence, Local; Vancomycin | 2023 |
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2023 |
Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Female; Humans; Intensive Care Units; Male; Metronidazole; Recurrence; Risk Factors; Singapore; Treatment Outcome; Vancomycin | 2019 |
Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; China; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Female; Hospitals, Teaching; Humans; Incidence; Male; Metronidazole; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Risk Factors; Tertiary Care Centers; Vancomycin | 2020 |
A preliminary study of bowel rest strategy in the management of Clostridioides difficile infection.
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease-Free Survival; Female; Humans; Male; Metronidazole; Retrospective Studies; Survival Rate; Vancomycin | 2020 |
Uncovering the Harms of Treating Clostridioides difficile Colonization.
Topics: Clostridioides; Clostridioides difficile; Diarrhea; Humans; Prospective Studies; Vancomycin | 2021 |
Toxigenic
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clostridioides difficile; Clostridium Infections; Diarrhea; DNA, Bacterial; Drug Therapy, Combination; Enterotoxins; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Polymerase Chain Reaction; Treatment Outcome; Vancomycin | 2021 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
Topics: Anti-Bacterial Agents; Asian People; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Diarrhea; Electrophoresis, Gel, Pulsed-Field; Feces; Genes, Bacterial; Hospitals; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Reproducibility of Results; Republic of Korea; Ribotyping; Vancomycin | 2017 |
Electrocardiogram Challenge Syncope in a Woman With Nausea and Diarrhea.
Topics: Aged; Cholecalciferol; Clonazepam; Diarrhea; Esomeprazole; Female; Fluconazole; Humans; Nausea; Ondansetron; Piperacillin, Tazobactam Drug Combination; Syncope; Torsades de Pointes; Vancomycin | 2017 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Female; Genotype; Hospitals, General; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin; Young Adult | 2018 |
Characterization of Chicken IgY Specific to
Topics: Adhesins, Bacterial; Administration, Oral; Animals; Antibodies, Bacterial; Bacterial Proteins; Caco-2 Cells; Chickens; Clostridioides difficile; Clostridium Infections; Colon; Diarrhea; Disease Models, Animal; Drug Combinations; Feces; Humans; Immunization, Passive; Immunoglobulin G; Immunoglobulins; Immunotherapy; Intestines; Mice; Mice, Inbred C57BL; Spores, Bacterial; Vancomycin | 2017 |
Fidaxomicin versus Vancomycin as a First-Line Treatment for Clostridium difficile-Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic Evaluation.
Topics: Aminoglycosides; Clostridium Infections; Cost Savings; Diarrhea; Fidaxomicin; Health Care Costs; Hospitalization; Humans; Models, Economic; Vancomycin | 2017 |
Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Inpatients; Leukocyte Count; Male; Metronidazole; Middle Aged; Neutrophils; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
Topics: Anti-Infective Agents; Bacterial Proteins; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Moxifloxacin; Tertiary Care Centers; Vancomycin | 2018 |
Clostridium innocuum is a vancomycin-resistant pathogen that may cause antibiotic-associated diarrhoea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Clostridium; Clostridium Infections; Diarrhea; Female; Humans; Infant; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Young Adult | 2018 |
Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Recurrence; Retrospective Studies; Transplant Recipients; Treatment Outcome; Vancomycin | 2018 |
Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Glycogen Storage Disease Type II; Humans; Immunocompetence; Infant; Metronidazole; Polymerase Chain Reaction; Treatment Outcome; Vancomycin | 2018 |
The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Drug Resistance, Bacterial; Fecal Microbiota Transplantation; Female; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Outcome and Process Assessment, Health Care; Recurrence; South Africa; Vancomycin | 2018 |
Firvanq--vancomycin oral solution.
Topics: Administration, Oral; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Drug Approval; Enterocolitis; Humans; Methicillin-Resistant Staphylococcus aureus; Solutions; Staphylococcal Infections; Staphylococcus aureus; United States; United States Food and Drug Administration; Vancomycin | 2018 |
A Case of Recurring Diarrhea in a Young Woman.
Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Recurrence; Vancomycin | 2019 |
Fidaxomicin in the treatment of Clostridium difficile infection in oncohematology patients.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonic Neoplasms; Diarrhea; Female; Fidaxomicin; Hematologic Neoplasms; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2019 |
Clostridium difficile-associated diarrhea following the therapy with antibiotic and proton pump inhibitors in a 77-year-old man with several comorbidities: A case report.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Comorbidity; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Proton Pump Inhibitors; Vancomycin | 2019 |
Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Feces; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Intestine, Small; Male; Metronidazole; Postoperative Complications; Prevalence; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2020 |
A new strategy for the prevention of Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides difficile; Clostridium Infections; Colistin; Diarrhea; Dose-Response Relationship, Drug; Feces; Female; Gentamicins; Kanamycin; Metagenome; Metronidazole; Mice; Mice, Inbred C57BL; Spores, Bacterial; Vancomycin | 2013 |
Duodenal infusion of stool is more effective than vancomycin in patients with recurrent Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colon; Diarrhea; Disease Models, Animal; Drug Evaluation, Preclinical; Fluoroquinolones; Germ-Free Life; Kaplan-Meier Estimate; Pyrimidinones; Severity of Illness Index; Swine; Treatment Outcome; Vancomycin | 2013 |
Duodenal infusion of feces for recurrent Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
Duodenal infusion of feces for recurrent Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
Duodenal infusion of feces for recurrent Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
Duodenal infusion of feces for recurrent Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
Duodenal infusion of feces for recurrent Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea.
Topics: Adult; Aged; Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Hematopoietic Stem Cell Transplantation; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Survival Analysis; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2013 |
The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Costs; Humans; Metronidazole; Severity of Illness Index; Vancomycin | 2013 |
Medical research. The promise of poop.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Diseases; Humans; Metagenome; Randomized Controlled Trials as Topic; Transplantation; Vancomycin | 2013 |
Fecal transplantation: beyond the aesthetic.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
Reply: To PMID 23323867.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.
Topics: Administration, Oral; Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Feces; Female; Humans; Male; Metronidazole; Microbiota; Middle Aged; Prospective Studies; Vancomycin | 2013 |
Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2013 |
Reply to M.R. Green et al.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 2013 |
Is fidaxomicin the drug of choice for treating Clostridium difficile-associated diarrhea in patients with cancer?
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 2013 |
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Proton Pump Inhibitors; Risk Factors; Treatment Outcome; Vancomycin | 2013 |
[Stool transplantation for relapsing Cl. difficile colitis].
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
Therapeutic approaches for Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Infective Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitoxins; Bacterial Vaccines; Biological Therapy; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Fidaxomicin; Humans; Immunotherapy; Metronidazole; Vancomycin | 2013 |
Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2014 |
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin | 2014 |
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae.
Topics: Abdominal Pain; Biopsy, Needle; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin | 2015 |
Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Biological Therapy; Capsules; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Freezing; Humans; Irritable Bowel Syndrome; Male; Metronidazole; Microbiota; Recurrence; Transplantation, Homologous; Treatment Outcome; Vancomycin | 2015 |
Adynamic ileus and diarrhoea: a rare adverse effect of antidepressants.
Topics: Aged; Anti-Bacterial Agents; Antidepressive Agents; Colonoscopy; Diarrhea; Female; Humans; Iatrogenic Disease; Ileus; Metronidazole; Parenteral Nutrition; Recurrence; Treatment Outcome; Vancomycin | 2015 |
Continuous Administration of Vancomycin through a Long Intestinal Tube for Clostridium difficile Infection.
Topics: Administration, Rectal; Aged; Anti-Bacterial Agents; Asian People; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Treatment Outcome; Vancomycin | 2015 |
Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Diarrhea; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Readmission; Retrospective Studies; Skin Diseases, Bacterial; Vancomycin | 2015 |
[Analysis of Clostridium difficile associated diarrhea in pediatric patients with antibiotic-associated diarrhea].
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Humans; Incidence; Metronidazole; Probiotics; Vancomycin | 2015 |
[Fecal microbiota transplantation in recurrent Clostridium difficile infection. Report of one case].
Topics: Clostridioides difficile; Clostridium Infections; Diarrhea; Fecal Microbiota Transplantation; Female; Humans; Middle Aged; Recurrence; Vancomycin | 2015 |
U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Multiplex Polymerase Chain Reaction; Prohibitins; Sentinel Surveillance; United States; Vancomycin | 2015 |
[Vancomycin intoxication in a patient with inappropriate antidiuretic hormone syndrome and diarrhea].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Diarrhea; Humans; Inappropriate ADH Syndrome; Kidney Diseases; Male; Vancomycin | 2015 |
Routine disc diffusion antimicrobial susceptibility testing of Clostridium difficile and association with PCR ribotype 027.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Metronidazole; Ribotyping; Vancomycin | 2015 |
Diarrhea With Clostridium difficile-Positive Stool-Trick or Treat: A Teachable Moment.
Topics: Aged; Anti-Bacterial Agents; Axitinib; Carcinoma, Renal Cell; Clostridioides difficile; Costs and Cost Analysis; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Imidazoles; Indazoles; Metronidazole; Protein Kinase Inhibitors; Recurrence; Treatment Outcome; Vancomycin; Withholding Treatment | 2015 |
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Diarrhea; Fidaxomicin; Humans; Kidney Diseases; Neoplasms; Quality-Adjusted Life Years; Spain; Treatment Outcome; Vancomycin | 2015 |
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Intestines; Metronidazole; Mice; Microbial Sensitivity Tests; Oxazolidinones; Streptococcal Infections; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Hypo-Hypo: A Complex Metabolic Disorder.
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fludrocortisone; Humans; Hyperkalemia; Hypoaldosteronism; Kidney; Male; Mineralocorticoids; Treatment Outcome; Vancomycin | 2016 |
Clostridium difficile Associated Diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Vancomycin | 2016 |
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin | 2016 |
High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Carrier State; Ceftriaxone; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Feces; Female; Ghana; Hospitalization; Humans; Infant; Infant, Newborn; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Ribotyping; Risk Factors; Rural Population; Vancomycin; Young Adult | 2016 |
Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Infant; Infant, Newborn; Italy; Male; Metronidazole; Prevalence; Recurrence; Retrospective Studies; Risk Assessment; Treatment Outcome; Vancomycin | 2017 |
[Clostridium difficile infection : What is currently available for treatment?]
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Fidaxomicin; Humans; Megacolon, Toxic; Metronidazole; Treatment Outcome; Vancomycin | 2016 |
Lack of Benefit With Combination Therapy for Clostridium difficile Infection.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Combined Modality Therapy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Length of Stay; Male; Metronidazole; Middle Aged; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Electronic Data Processing; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Female; Hospital Information Systems; Humans; Laxatives; Male; Metronidazole; Middle Aged; Vancomycin | 2017 |
Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2009 |
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vancomycin | 2008 |
Antibiotic prescribing.
Topics: Anti-Bacterial Agents; Cellulitis; Clindamycin; Clostridioides difficile; Diarrhea; Humans; Medical Staff, Hospital; Metronidazole; Penicillins; Pneumonia; Professional Practice; Urinary Tract Infections; Vancomycin | 2008 |
A mouse model of Clostridium difficile-associated disease.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Disease Models, Animal; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Mice; Mice, Inbred C57BL; Severity of Illness Index; Vancomycin | 2008 |
Management of Clostridium difficile infection: survey of practices and compliance with national guidelines among primary care physicians.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Guideline Adherence; Health Care Surveys; Metronidazole; Physicians, Family; Practice Guidelines as Topic; Practice Patterns, Physicians'; Vancomycin | 2009 |
Clostridium difficile-associated diarrhea in Crohn's disease patients with ostomy.
Topics: Adult; Clostridioides difficile; Colectomy; Crohn Disease; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Ostomy; Postoperative Complications; Prognosis; Vancomycin | 2010 |
Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients.
Topics: Aged, 80 and over; Albumins; Anti-Bacterial Agents; C-Reactive Protein; Clostridioides difficile; Clostridium Infections; Creatinine; Cross Infection; Diarrhea; Female; Hospitals; Humans; Leukocyte Count; Male; Metronidazole; Time Factors; United Kingdom; Vancomycin | 2010 |
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2010 |
Treatment of clostridium difficile infection.
Topics: Anti-Infective Agents; Bacterial Infections; Clostridioides difficile; Diarrhea; Drugs, Investigational; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin | 2011 |
Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Diarrhea; Enzyme-Linked Immunosorbent Assay; Feces; Female; Hospitals, General; Humans; India; Male; Metronidazole; Middle Aged; Prevalence; Retrospective Studies; Vancomycin | 2011 |
Imipenem-induced Clostridium difficile diarrhea in a patient with chronic renal failure.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Imipenem; Kidney Failure, Chronic; Male; Pneumonia; Vancomycin | 2011 |
Sacroiliitis caused by Salmonella typhi: a case report.
Topics: Anti-Bacterial Agents; Blood Sedimentation; C-Reactive Protein; Diarrhea; Humans; Levofloxacin; Magnetic Resonance Imaging; Male; Ofloxacin; Pelvic Bones; Radiography; Sacroiliac Joint; Sacroiliitis; Salmonella typhi; Typhoid Fever; Vancomycin; Young Adult | 2011 |
Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Republic of Korea; Treatment Outcome; Vancomycin | 2011 |
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Vancomycin | 2012 |
Preventing downstream Clostridium difficile infections with upstream antibiotic management.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin | 2012 |
Progress with a difficult infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Vancomycin | 2012 |
A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, Military; Humans; Incidence; Inpatients; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Military Medicine; Outpatients; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States; Vancomycin; Veterans | 2012 |
Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Diarrhea; Endpoint Determination; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Polymers; Sulfonic Acids; Treatment Outcome; Vancomycin | 2012 |
Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Diarrhea; Drug Administration Routes; Drug Administration Schedule; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Probiotics; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin | 2013 |
Pneumatosis intestinalis in a patient with recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colic; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Pneumatosis Cystoides Intestinalis; Recurrence; Tomography, X-Ray Computed; Vancomycin | 2012 |
Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Clostridioides difficile; Clostridium Infections; Diarrhea; Disease Models, Animal; Gene Deletion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2A; Secondary Prevention; Survival Analysis; Vancomycin | 2012 |
Fecal microbiota transplantation--an old therapy comes of age.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Feces; Female; Humans; Male; Vancomycin | 2013 |
[Role of Clostridium difficile infection in the relapse of ulcerative colitis].
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Treatment Outcome; Vancomycin | 2002 |
[Antibiotic-associated diarrhea].
Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Metronidazole; Recurrence; Vancomycin | 2003 |
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chi-Square Distribution; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Progression; Female; Humans; Incidence; Logistic Models; Male; Metronidazole; Middle Aged; Quebec; Retrospective Studies; Severity of Illness Index; Vancomycin | 2004 |
Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
Topics: Animals; Anti-Bacterial Agents; Cecum; Clostridioides difficile; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Enzyme-Linked Immunosorbent Assay; Mesocricetus; Microbial Sensitivity Tests; Rifamycins; Secondary Prevention; Survival Analysis; Vancomycin; Weight Loss | 2004 |
Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
Topics: Anti-Bacterial Agents; Diarrhea; Endoscopy, Gastrointestinal; Enterocolitis, Pseudomembranous; Feces; Humans; Immunoenzyme Techniques; Metronidazole; Recurrence; Risk Factors; Vancomycin | 2004 |
Treating C. difficile.
Topics: Anion Exchange Resins; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Interactions; Drug Therapy, Combination; Metronidazole; Vancomycin | 2005 |
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Topics: Adult; Aged; Cephalosporins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Lymphoma; Male; Middle Aged; Multiple Myeloma; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Autologous; Vancomycin | 2006 |
Severe diarrhea and shock.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Severity of Illness Index; Shock; Vancomycin | 2006 |
Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; C-Reactive Protein; Clostridioides difficile; Colitis; Diarrhea; Humans; Hypoalbuminemia; Immunoglobulins, Intravenous; Leukocyte Count; Metronidazole; Middle Aged; Proteins; Retrospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Vancomycin | 2006 |
[Pseudomembraneous colitis caused by a toxin B-positive and a toxin A-negative strain of Clostridium difficile].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Intestinal Mucosa; Vancomycin | 2006 |
Vancomycin-induced elevation of liver enzyme levels.
Topics: Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Liver; Liver Function Tests; Male; Metronidazole; Middle Aged; Vancomycin | 2006 |
[Occurrence and treatment of Clostridium difficile-associated diarrhea].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2006 |
Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
Topics: Adult; Age Factors; Aged; Clostridioides difficile; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rifamycins; Rifaximin; Risk Factors; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Vancomycin | 2007 |
[Clostridium difficile associated diarrhea in the elderly patient].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2007 |
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin | 2007 |
A case of recurrent Clostridium difficile diarrhea.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Recurrence; Treatment Failure; Vancomycin | 2007 |
Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Vancomycin | 2007 |
Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2007 |
Clostridium difficile-associated disease treatment response depends on definition of cure.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Humans; Metronidazole; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2007 |
Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Kaplan-Meier Estimate; Metronidazole; Middle Aged; Proportional Hazards Models; Prospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2008 |
Cefotaxime-associated diarrhea and Clostridium difficile.
Topics: Arthritis, Rheumatoid; Cefotaxime; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Middle Aged; Prednisolone; Pulmonary Fibrosis; Vancomycin | 1984 |
Cost of vancomycin.
Topics: Clostridium Infections; Costs and Cost Analysis; Diarrhea; Humans; Vancomycin | 1983 |
Metronidazole or vancomycin for Clostridium difficile associated diarrhoea.
Topics: Clostridium Infections; Diarrhea; Humans; Metronidazole; Vancomycin | 1983 |
Treatment of antibiotic-associated colitis with vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Vancomycin | 1984 |
Pseudomembranous colitis with recurring diarrhoea and prolonged persistence of Clostridium difficile in a 10-year-old girl.
Topics: Amoxicillin; Carrier State; Child; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Recurrence; Vancomycin | 1984 |
Clostridium difficile colitis associated with the use of antineoplastic agents.
Topics: Adult; Aged; Antineoplastic Agents; Clostridium; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Male; Methotrexate; Middle Aged; Vancomycin | 1984 |
Absorption of vancomycin.
Topics: Aged; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Intestinal Absorption; Male; Middle Aged; Vancomycin | 1984 |
Diet as a coadjuvant for development of antibiotic-associated diarrhea in hamsters (Mesocricetus auratus).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Animals, Laboratory; Clostridium; Cricetinae; Diarrhea; Diet; Male; Mesocricetus; Neomycin; Neoplasms, Experimental; Rodent Diseases; Vancomycin | 1981 |
Chronic diarrhea associated with Clostridium difficile in children.
Topics: Bacterial Toxins; Child; Child, Preschool; Clostridium; Clostridium Infections; Diarrhea; Feces; Humans; Immunoassay; Infant; Vancomycin | 1983 |
Antibiotic-associated diarrhoea and pseudomembranous colitis caused by Clostridium difficile. A review of 40 cases.
Topics: Adult; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Vancomycin | 1983 |
Clostridium difficile colitis associated with cancer chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bone Neoplasms; Clostridium Infections; Colitis; Colonic Neoplasms; Diarrhea; Humans; Humerus; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Vancomycin | 1982 |
Antibiotic-associated diarrhoea and methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacitracin; Cross Infection; Diarrhea; Feces; Humans; Male; Methicillin; Microbiological Techniques; Middle Aged; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Clostridium difficile: epidemiology and clinical features.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Carrier State; Clostridium; Clostridium Infections; Diarrhea; Feces; Female; Humans; Male; Middle Aged; Nova Scotia; Vancomycin | 1982 |
Diarrhea we can treat: antibiotic-associated colitis.
Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Vancomycin | 1982 |
Antimicrobial agent-associated colitis and diarrhea.
Topics: Animals; Anti-Bacterial Agents; Clostridium Infections; Colitis; Cricetinae; Diarrhea; Humans; Infant; Infant, Newborn; Vancomycin | 1980 |
Pseudomembranous colitis: multiple relapses after treatment with metronidazole.
Topics: Aged; Cholestyramine Resin; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Metronidazole; Recurrence; Vancomycin | 1981 |
Antimicrobial agent-associated colitis and diarrhea.
Topics: Anti-Bacterial Agents; Clostridium Infections; Colitis; Diarrhea; Humans; Vancomycin | 1981 |
[Severe diarrhea associated with antibiotics].
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Clostridium; Diarrhea; Feces; Female; Humans; Male; Middle Aged; Vancomycin | 1981 |
Treatment of Clostridium difficile colitis and diarrhea with vancomycin.
Topics: Adolescent; Adult; Aged; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Infant, Newborn; Male; Middle Aged; Recurrence; Vancomycin | 1981 |
Treatment of antibiotic-associated Clostridium difficile diarrhea with oral vancomycin.
Topics: Anti-Bacterial Agents; Child; Clostridium Infections; Diarrhea; Diarrhea, Infantile; Female; Humans; Infant, Newborn; Male; Vancomycin | 1980 |
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cholestyramine Resin; Clostridium Infections; Cricetinae; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Rabbits; Vancomycin | 1980 |
Community-acquired Clostridium difficile-associated diarrhea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Toxins; Child; Child, Preschool; Clostridioides difficile; Community-Acquired Infections; Cytotoxins; Diarrhea; Feces; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 1995 |
Management and control of a large outbreak of diarrhoea due to Clostridium difficile.
Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; England; Enterotoxins; Hospitals, General; Humans; Infection Control; Metronidazole; Middle Aged; Recurrence; Vancomycin | 1994 |
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cross Infection; Diarrhea; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Middle Aged; Rhode Island; Vancomycin | 1994 |
Clostridium difficile infection is a treatable cause of diarrhea in patients with advanced human immunodeficiency virus infection: a study of seven consecutive patients admitted from 1986 to 1992 to a university teaching hospital.
Topics: Adult; AIDS-Related Opportunistic Infections; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Humans; Male; Metronidazole; Vancomycin | 1993 |
Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacterial Toxins; Case-Control Studies; Chi-Square Distribution; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Leukocyte Count; Male; Metronidazole; Vancomycin | 1993 |
Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antidiarrheals; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Loperamide; Macrolides; Male; Metronidazole; Middle Aged; Retrospective Studies; Time Factors; Vancomycin | 1995 |
Diarrhoea in the intensive care unit.
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Cross Infection; Diarrhea; Humans; Intensive Care Units; Metronidazole; Vancomycin | 1997 |
[Clostridium difficile toxin-associated diarrhea in geriatrics].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Frail Elderly; Humans; Male; Risk Factors; Vancomycin | 1998 |
Managing C. difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Microbial; Humans; Metronidazole; United States; Vancomycin | 1998 |
Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Prospective Studies; Vancomycin | 1999 |
Enterococci with reduced susceptibility to vancomycin in New Zealand.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Diarrhea; DNA Fingerprinting; DNA, Bacterial; DNA, Ribosomal; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Feces; Glucosides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; New Zealand; Prevalence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2000 |
The detection of Shiga toxin-producing Escherichia coli in diagnostic bovine faecal samples using vancomycin-cefixime-cefsulodin blood agar and PCR.
Topics: Adhesins, Bacterial; Animals; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacteriological Techniques; Carrier Proteins; Cattle; Cattle Diseases; Cefixime; Cefsulodin; Culture Media; Diarrhea; Escherichia coli; Escherichia coli Proteins; Feces; Hemolysin Proteins; Polymerase Chain Reaction; Serotyping; Shiga Toxin 1; Shiga Toxin 2; Vancomycin; Virulence | 2001 |
Non-HIV highlights of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy.
Topics: Acyclovir; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Candidiasis; Cryptosporidium; Diarrhea; Drug Carriers; Drug Resistance, Microbial; Gram-Positive Bacteria; Hepatitis A; Herpes Genitalis; Valacyclovir; Valine; Vancomycin | 1995 |
Saccharomyces boulardii: potential adjunctive treatment for children with autism and diarrhea.
Topics: Anti-Bacterial Agents; Autistic Disorder; Diarrhea; Humans; Probiotics; Saccharomyces; Vancomycin | 2001 |
Clinical microbiological case: a heart transplant recipient with diarrhea and abdominal pain. Recurring C. difficile infection.
Topics: Abdominal Pain; Adult; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Male; Metronidazole; Vancomycin | 2001 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
Value of Clostridium difficile antigen test in immunocompromised hosts in the tropics.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fusidic Acid; Humans; Immunocompromised Host; Tropical Climate; Vancomycin | 1991 |
[A case of antibiotic-associated diarrhea caused by Clostridium difficile and treated with vancomycin].
Topics: Aged; Clostridium; Clostridium Infections; Diarrhea; Female; Humans; Lincomycin; Toxins, Biological; Vancomycin | 1979 |
Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea.
Topics: Animals; Cecum; Clindamycin; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Enterocolitis, Pseudomembranous; Intestinal Mucosa; Mesocricetus; Microscopy, Electron; Vancomycin | 1979 |
Antibiotic susceptibility of Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Miconazole; Microbial Sensitivity Tests; Vancomycin | 1979 |
Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage.
Topics: Animals; Autopsy; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Colitis; Colon; Diarrhea; DNA; Enterocolitis, Pseudomembranous; Ileitis; Intestinal Mucosa; Male; Rabbits; Vancomycin | 1978 |
Diarrhea in hospitalized patients.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cytotoxins; Diarrhea; Feces; Humans; Inpatients; Metronidazole; Middle Aged; Rehabilitation Centers; Vancomycin | 1992 |
Antibiotic resistance of Clostridium difficile isolates.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Clostridioides difficile; Diarrhea; Drug Resistance, Microbial; Glycopeptides; Humans; Infant; Infant, Newborn; Leukemia; Metronidazole; Poland; Teicoplanin; Vancomycin | 1991 |
Recovery of vancomycin-resistant gram-positive cocci from children.
Topics: Child; Cross-Sectional Studies; Culture Media; Diarrhea; Drug Resistance, Microbial; Enterococcus faecalis; Feces; Gram-Positive Bacteria; Humans; Lactobacillus; Leuconostoc; Sepsis; Streptococcus; Vancomycin | 1990 |
[Clinical study of pseudomembranous colitis: a neurosurgical viewpoint].
Topics: Aged; Anti-Bacterial Agents; Brain Diseases; Cerebral Hemorrhage; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Postoperative Complications; Vancomycin | 1990 |
Inappropriate antibiotic use and the development of Clostridium difficile colitis.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin | 1990 |
[Antibiotic associated diarrhea].
Topics: Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 1990 |
Comparison of two oral formulations of vancomycin for treatment of diarrhoea associated with Clostridium difficile.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clostridium; Clostridium Infections; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Vancomycin | 1989 |
Treatment of Clostridium difficile diarrhea.
Topics: Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 1989 |
Prevention of Clostridium difficile outbreaks in hospitals.
Topics: Clostridium; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Vancomycin | 1986 |
Clostridium difficile toxin in chronic idiopathic colitis.
Topics: Adult; Bacterial Proteins; Bacterial Toxins; Chronic Disease; Clostridium; Clostridium Infections; Colitis; Colitis, Ulcerative; Crohn Disease; Diarrhea; Female; Humans; Male; Sulfasalazine; Vancomycin | 1986 |
Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine.
Topics: Anti-Bacterial Agents; Cholestyramine Resin; Clostridium; Diarrhea; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Glycopeptides; Humans; Teicoplanin; Vancomycin | 1985 |
Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.
Topics: Aged; Aged, 80 and over; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Recurrence; Vancomycin | 1987 |
Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.
Topics: Adult; Aged; Aged, 80 and over; Clostridium; Clostridium Infections; Colitis; Diarrhea; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Vancomycin | 1987 |
The effects of acute clostridium difficile diarrhea on fecal nitrogen content in adult hospitalized patients.
Topics: Adult; Aged; Body Weight; Clostridium Infections; Diarrhea; Energy Intake; Feces; Female; Humans; Male; Middle Aged; Nitrogen; Nutritional Status; Serum Albumin; Vancomycin | 1987 |
The significance of quantitative results of C. difficile cultures and toxin assays in patients with diarrhea.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Toxins; Bacteriological Techniques; Child; Child, Preschool; Clostridium; Colitis; Diarrhea; Feces; Female; Humans; Infant; Male; Middle Aged; Retrospective Studies; Vancomycin | 1985 |
Clostridium difficile colitis following head and neck surgery. Report of cases.
Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Head and Neck Neoplasms; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Premedication; Vancomycin | 1985 |